Behrouz Zand MD, MS blogs at Digital Antidote – The Collision of Medicine, Philosophy and Social Science. His post of January 16, 2018, is entitled “Why only fixing U.S. healthcare will not make us healthier.” Here is my response March 4, 2018: Dr. Zand: I echo the praise for your excellent essay. In support, I … Continue reading Response to “Why Only Fixing U.S. Healthcare Will Not Make Us Healthier”
Category: Cost-benefit research
Genes, Cost-Effectiveness and Healthcare Reform – Dialog with Dr. Buchanan
This is a posting of my reply to British health economist Dr. Buchanan's Comment of February 17, 2018. The original posts are: Medicines's future? The health economics of population-wide genomic screening (October 26, 2017) Cost-Effectiveness: From Genes to Healthcare System Reform (December 17, 2017) 2 thoughts on “Cost-Effectiveness: From Genes to Healthcare System Reform” (Reply, February … Continue reading Genes, Cost-Effectiveness and Healthcare Reform – Dialog with Dr. Buchanan
Elevator Pitch for Oregon-style Healthcare Reform
Jack Welch, the former CEO of General Electric, was famous for cornering his managers to justify their projects with an “elevator pitch” that could be delivered to him during a short ride from one floor to the next. Here’s mine pushing for healthcare reform and an Oregon-style cost-benefit analysis approach: You know, of course, how … Continue reading Elevator Pitch for Oregon-style Healthcare Reform
Cost-Effectiveness: From Genes to Healthcare System Reform
British health economist James Buchanan D.Phil. is skeptical that Geisinger Health System’s (Pa.) genomics project will prove to be cost-effective. But what about the cost-effectiveness of the whole U.S. health system? As a physician and resident of the southern reaches of Geisinger Health System’s catchment area in central Pennsylvania, I was intrigued by Dr. Buchanan’s … Continue reading Cost-Effectiveness: From Genes to Healthcare System Reform
Will New Trump-GOP Tax Plan Trigger PAYGO Cuts to Medicare?
The Trump-GOP tax plan will add to the national debt by $1 trillion (Joint Committee on Taxation) or $1.4 trillion (Congressional Budget Office). Under the pay-as-you-go (PAYGO) law, Congress will need to make a choice to cut Medicare or to allow the increase of the national debt. The PAYGO law says that the revenue shortfall … Continue reading Will New Trump-GOP Tax Plan Trigger PAYGO Cuts to Medicare?
Fixing U.S. Healthcare 